| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PTEN Phosphohydrolase | 18 | 2015 | 88 | 2.830 |
Why?
|
| Tumor Suppressor Proteins | 11 | 2015 | 210 | 2.090 |
Why?
|
| Glioblastoma | 10 | 2016 | 160 | 1.520 |
Why?
|
| Phosphoric Monoester Hydrolases | 9 | 2006 | 45 | 1.490 |
Why?
|
| Brain Neoplasms | 12 | 2016 | 318 | 1.480 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 4 | 2025 | 17 | 0.900 |
Why?
|
| Dacarbazine | 4 | 2016 | 18 | 0.890 |
Why?
|
| Phosphatidylinositols | 7 | 2025 | 51 | 0.760 |
Why?
|
| ErbB Receptors | 3 | 2024 | 127 | 0.650 |
Why?
|
| Glioma | 5 | 2010 | 99 | 0.640 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 461 | 0.620 |
Why?
|
| Cell Membrane | 5 | 2024 | 507 | 0.590 |
Why?
|
| Stem Cells | 5 | 2004 | 274 | 0.590 |
Why?
|
| Lipid Bilayers | 3 | 2025 | 53 | 0.550 |
Why?
|
| Neurons | 5 | 2003 | 940 | 0.530 |
Why?
|
| Antineoplastic Agents, Alkylating | 3 | 2014 | 33 | 0.510 |
Why?
|
| Epidermal Growth Factor | 5 | 2024 | 50 | 0.500 |
Why?
|
| Phosphatidylinositol Phosphates | 5 | 2024 | 40 | 0.490 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 51 | 0.480 |
Why?
|
| Biophysical Phenomena | 1 | 2015 | 23 | 0.450 |
Why?
|
| Cell Line, Tumor | 11 | 2016 | 1558 | 0.440 |
Why?
|
| Protein Binding | 8 | 2015 | 1640 | 0.400 |
Why?
|
| Signal Transduction | 7 | 2024 | 3149 | 0.400 |
Why?
|
| Animals | 26 | 2024 | 21312 | 0.330 |
Why?
|
| Biomarkers, Tumor | 3 | 2009 | 522 | 0.330 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 76 | 0.320 |
Why?
|
| Mutation | 6 | 2012 | 2658 | 0.310 |
Why?
|
| Mice, Nude | 5 | 2016 | 287 | 0.310 |
Why?
|
| Apoptosis | 7 | 2016 | 1094 | 0.300 |
Why?
|
| Phosphorylation | 7 | 2015 | 961 | 0.290 |
Why?
|
| Cell Division | 4 | 2010 | 448 | 0.290 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 19 | 0.290 |
Why?
|
| Membrane Proteins | 4 | 2013 | 922 | 0.280 |
Why?
|
| Mice | 17 | 2016 | 11102 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 1 | 2009 | 195 | 0.280 |
Why?
|
| Autistic Disorder | 1 | 2010 | 149 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2016 | 202 | 0.270 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 2024 | 5 | 0.270 |
Why?
|
| Unilamellar Liposomes | 2 | 2025 | 9 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 344 | 0.250 |
Why?
|
| Cell Nucleus | 2 | 2008 | 632 | 0.230 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 792 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2014 | 369 | 0.230 |
Why?
|
| Humans | 29 | 2024 | 64778 | 0.230 |
Why?
|
| Neuropeptides | 1 | 2005 | 81 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 116 | 0.220 |
Why?
|
| Nervous System | 2 | 2004 | 71 | 0.220 |
Why?
|
| Temperature | 2 | 2024 | 313 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2013 | 1031 | 0.210 |
Why?
|
| Magnesium | 1 | 2024 | 54 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 104 | 0.210 |
Why?
|
| Cell Movement | 2 | 2005 | 476 | 0.210 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2004 | 73 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 502 | 0.200 |
Why?
|
| Proteolysis | 1 | 2024 | 154 | 0.200 |
Why?
|
| Schizosaccharomyces | 1 | 2004 | 104 | 0.200 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2003 | 7 | 0.200 |
Why?
|
| Receptor, trkA | 1 | 2003 | 3 | 0.200 |
Why?
|
| Triazenes | 1 | 2002 | 2 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 217 | 0.190 |
Why?
|
| Drug Synergism | 1 | 2003 | 143 | 0.190 |
Why?
|
| Neuroblastoma | 1 | 2003 | 54 | 0.190 |
Why?
|
| Talin | 1 | 2022 | 3 | 0.180 |
Why?
|
| Brain | 3 | 2008 | 1594 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2003 | 227 | 0.170 |
Why?
|
| Calcium | 1 | 2024 | 583 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 3 | 2008 | 403 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 286 | 0.170 |
Why?
|
| Cell Differentiation | 6 | 2009 | 1382 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2003 | 200 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2008 | 610 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 312 | 0.160 |
Why?
|
| Protein Conformation | 4 | 2009 | 790 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 195 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 3 | 2010 | 426 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 3 | 2008 | 19 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2003 | 718 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 793 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2009 | 204 | 0.140 |
Why?
|
| Aniline Compounds | 2 | 2014 | 40 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 710 | 0.130 |
Why?
|
| DNA Primers | 4 | 2011 | 300 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2014 | 24 | 0.130 |
Why?
|
| Antineoplastic Agents | 3 | 2010 | 640 | 0.130 |
Why?
|
| Cell Survival | 2 | 2013 | 581 | 0.130 |
Why?
|
| Hydroxyquinolines | 1 | 2016 | 3 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 3 | 2008 | 430 | 0.110 |
Why?
|
| bcl-X Protein | 1 | 2015 | 24 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2008 | 2152 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2015 | 67 | 0.110 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 80 | 0.110 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 3468 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 152 | 0.110 |
Why?
|
| Codon, Initiator | 1 | 2014 | 11 | 0.110 |
Why?
|
| DNA Repair | 1 | 2016 | 251 | 0.110 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 10 | 0.110 |
Why?
|
| Phosphatidylserines | 2 | 2012 | 14 | 0.110 |
Why?
|
| Membrane Fluidity | 1 | 2014 | 15 | 0.110 |
Why?
|
| Databases, Protein | 1 | 2014 | 45 | 0.100 |
Why?
|
| Transfection | 4 | 2015 | 700 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 851 | 0.100 |
Why?
|
| Nestin | 3 | 2008 | 13 | 0.100 |
Why?
|
| Cerebral Ventricles | 2 | 2005 | 29 | 0.100 |
Why?
|
| Benzenesulfonates | 2 | 2010 | 13 | 0.100 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2010 | 25 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2010 | 1572 | 0.100 |
Why?
|
| Models, Biological | 2 | 2009 | 1203 | 0.100 |
Why?
|
| Amino Acids | 1 | 2014 | 148 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 2010 | 165 | 0.100 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 38 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 677 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2006 | 224 | 0.100 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2011 | 63 | 0.100 |
Why?
|
| Cholesterol | 1 | 2014 | 261 | 0.090 |
Why?
|
| Pyridines | 2 | 2010 | 115 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 439 | 0.090 |
Why?
|
| Cell Lineage | 3 | 2009 | 282 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 244 | 0.090 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 133 | 0.090 |
Why?
|
| Glycine | 1 | 2011 | 49 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 374 | 0.080 |
Why?
|
| Ethylnitrosourea | 3 | 2006 | 7 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 897 | 0.080 |
Why?
|
| Carmustine | 1 | 2010 | 11 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 2010 | 25 | 0.080 |
Why?
|
| Binding Sites | 3 | 2015 | 920 | 0.080 |
Why?
|
| Spheroids, Cellular | 1 | 2010 | 28 | 0.080 |
Why?
|
| Activating Transcription Factors | 1 | 2010 | 11 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 60 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 46 | 0.080 |
Why?
|
| Mitochondria | 2 | 2011 | 399 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2010 | 216 | 0.080 |
Why?
|
| Dipeptides | 1 | 2010 | 68 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 240 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2188 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 237 | 0.080 |
Why?
|
| Receptors, Notch | 1 | 2010 | 110 | 0.080 |
Why?
|
| Protein Multimerization | 2 | 2024 | 181 | 0.080 |
Why?
|
| Exons | 1 | 2010 | 205 | 0.080 |
Why?
|
| Culture Media | 1 | 2009 | 79 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 178 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 289 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 17 | 0.070 |
Why?
|
| Karyotyping | 1 | 2008 | 48 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 99 | 0.070 |
Why?
|
| Retroviridae | 1 | 2008 | 75 | 0.070 |
Why?
|
| Integrases | 1 | 2008 | 41 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 583 | 0.070 |
Why?
|
| Centrosome | 1 | 2008 | 71 | 0.070 |
Why?
|
| Rats | 4 | 2006 | 1996 | 0.070 |
Why?
|
| Protein Folding | 2 | 2015 | 269 | 0.070 |
Why?
|
| Time Factors | 3 | 2006 | 3753 | 0.070 |
Why?
|
| Forecasting | 1 | 2007 | 229 | 0.060 |
Why?
|
| Male | 5 | 2016 | 30812 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 20 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 9 | 0.060 |
Why?
|
| Prognosis | 1 | 2010 | 1773 | 0.060 |
Why?
|
| Dentate Gyrus | 1 | 2005 | 12 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1592 | 0.060 |
Why?
|
| Diffusion | 1 | 2005 | 82 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 152 | 0.060 |
Why?
|
| Bromodeoxyuridine | 2 | 2002 | 43 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2005 | 193 | 0.060 |
Why?
|
| Astrocytes | 1 | 2006 | 121 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2005 | 18 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 53 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1188 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 285 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2024 | 25 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2004 | 46 | 0.050 |
Why?
|
| Microtubules | 1 | 2005 | 211 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2005 | 98 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 409 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 12 | 0.050 |
Why?
|
| Lysosomes | 1 | 2024 | 171 | 0.050 |
Why?
|
| Allosteric Site | 1 | 2003 | 31 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 1285 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 54 | 0.050 |
Why?
|
| Blastocyst | 1 | 2004 | 74 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2003 | 2 | 0.050 |
Why?
|
| Tensins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 5 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2003 | 8 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 27 | 0.050 |
Why?
|
| Neurites | 1 | 2003 | 23 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 147 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 78 | 0.050 |
Why?
|
| Dithiothreitol | 1 | 2002 | 18 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 39 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 156 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 33 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 197 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 58 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 31 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 5764 | 0.050 |
Why?
|
| Phosphates | 1 | 2003 | 102 | 0.050 |
Why?
|
| Glutathione | 1 | 2002 | 55 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 298 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 389 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2003 | 112 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 108 | 0.050 |
Why?
|
| Catalysis | 1 | 2003 | 164 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2003 | 135 | 0.050 |
Why?
|
| Female | 8 | 2010 | 33765 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 251 | 0.050 |
Why?
|
| Olfactory Bulb | 1 | 2002 | 19 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 107 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 364 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 197 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 129 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 115 | 0.050 |
Why?
|
| Cell Separation | 1 | 2002 | 147 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 176 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 347 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 450 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2003 | 311 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2002 | 131 | 0.040 |
Why?
|
| Kinetics | 1 | 2003 | 758 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2003 | 666 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 214 | 0.040 |
Why?
|
| Neoplasms | 1 | 2011 | 1357 | 0.040 |
Why?
|
| Niacinamide | 2 | 2010 | 32 | 0.040 |
Why?
|
| Phenylurea Compounds | 2 | 2010 | 31 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2002 | 317 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2010 | 168 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 856 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 449 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2006 | 623 | 0.040 |
Why?
|
| Cell Line | 2 | 2015 | 2036 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1984 | 0.040 |
Why?
|
| Autophagy | 2 | 2010 | 232 | 0.030 |
Why?
|
| Pregnancy | 4 | 2006 | 2363 | 0.030 |
Why?
|
| Scattering, Small Angle | 1 | 2015 | 16 | 0.030 |
Why?
|
| Base Sequence | 2 | 2011 | 1328 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2015 | 61 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 23 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 86 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 7 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 260 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2014 | 38 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 493 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 315 | 0.030 |
Why?
|
| Indazoles | 1 | 2014 | 19 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 419 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 518 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2002 | 1550 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2006 | 154 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2014 | 144 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2014 | 136 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 325 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 396 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 292 | 0.020 |
Why?
|
| Neutrons | 1 | 2012 | 2 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 32 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 12 | 0.020 |
Why?
|
| Guanidines | 1 | 2011 | 13 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2011 | 28 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 31 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 355 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 211 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2277 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2015 | 708 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2010 | 12 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 203 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 68 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 200 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 140 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 108 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 436 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 543 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2011 | 209 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 198 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 416 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 56 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 643 | 0.020 |
Why?
|
| Osteopontin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2005 | 13 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 267 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 980 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 27 | 0.010 |
Why?
|
| Carcinogens | 1 | 2004 | 33 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 42 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2004 | 41 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 129 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 512 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 173 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 259 | 0.010 |
Why?
|
| Antimetabolites | 1 | 2002 | 18 | 0.010 |
Why?
|
| Clone Cells | 1 | 2002 | 112 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2004 | 141 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 1210 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 870 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 1468 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 14840 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 17243 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 18112 | 0.010 |
Why?
|